For most of human history, medical treatment has relied on methods such as pills, injections, and surgery. Now, scientists are exploring a new idea: making tiny, programmable machines from DNA that can move through the bloodstream.
A recent review published in the journal SmartBot says these DNA nanorobots could one day be capable of delivering drugs to specific locations in the body, capturing viruses like SARS-CoV-2, and even helping build tiny computing devices. Even though these ideas are exciting, the technology is still in its early stages.
Early Stages of Development
The concept of DNA robotics draws on ideas from traditional engineering. Scientists have applied concepts from traditional robotics, such as rigid systems, flexible mechanisms, and folding designs inspired by origami; however, these operate at a much smaller scale, making them almost impossible to visualize. In fact, these DNA machines are measured in nanometers, which are one billionth of a meter.
DNA works well as a building material because it follows strict base-pairing rules. These rules allow engineers to design DNA sequences that fold, connect, and reconfigure themselves in controlled ways. This reliability is key to developing machines that must work consistently within the body. Right now, most DNA robots are just early prototype models that serve as proof-of-concept. They are not yet ready for use in real medical trials and treatments.
The Control Problem
Reliably navigating these machines at such a tiny scale presents challenges. At this size, molecules are constantly randomly moving, a process called Brownian motion, making them difficult to precisely control.
Scientists have identified two main ways to control DNA robots. One method uses chemical reactions, such as DNA strand displacement, in which certain DNA sequences act as fuel to drive the robots to move or change shape. The other method uses signals from outside the body, such as electrical, magnetic, or light signals, to guide or activate the robots. These methods help scientists control DNA robots even in places where everything is constantly moving.
Potential Applications
Scientists are exploring medical applications that could change how we treat diseases. In the future, DNA robots could function as what researchers describe as “nano-surgeons”, finding diseased cells and delivering therapeutic compounds directly to them. This could help reduce negative side effects that often accompany conventional treatments such as chemotherapy.
Researchers are also investigating whether these DNA machines can be designed to catch viruses, including SARS-CoV-2. This idea is not just a theory; early experiments have already shown that these machines can bind to and interact with specific molecular targets.
The same precision that makes DNA robots appealing for targeted drug delivery also makes them useful for nanoscale manufacturing. Programmable templates could position nanoparticles with extraordinary accuracy. This capability has potential applications in molecular computing and advanced optical systems.
Remaining Obstacles
DNA robotics has made real progress, but it will take time to turn lab experiments into useful tools. Scientists have found several problems that need to be solved before these robots can be used with patients.
One big challenge is that the field still lacks comprehensive databases describing the mechanical properties of DNA structures. Tools for predicting how these machines will work in real-life situations are still being developed. Because of this, designing robots for certain jobs often takes a lot of trial and error.
The review points out the need for libraries of standard DNA parts, like catalogs of pieces that can be put together in predictable ways, similar to modular parts in manufacturing. The authors also suggest that artificial intelligence could accelerate both the design process and the development of better simulation tools.
Machines of the Future
The concept of DNA robots is significant, even beyond their technical promise. For decades, the prevailing vision of advanced technology has focused on faster processors and stronger materials built from silicon and steel. DNA robots take a new path by using biological molecules as the base for machines.
“The robots of tomorrow won’t just be made of metal and plastic,” the research team writes. “They will be biological, programmable, and intelligent. They will be the tools that allow us to finally master the molecular world.”
Austin Burgess is a writer and researcher with a background in sales, marketing, and data analytics. He holds an MBA, a Bachelor of Science in Business Administration, and a data analytics certification. His work focuses on breaking scientific developments, with an emphasis on emerging biology, cognitive neuroscience, and archaeological discoveries.